RHUMBLINE ADVISERS

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in LENZ

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$205,655

-$118,345 QoQ

Shares Held

22,476

+11.0% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 21.73874354867414.ToString("F0")% Shared 0.ToString("F0")% None 78.26125645132585.ToString("F0")%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. LENZ ranks #202 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	423,140	$188,948,935
2	REGN	Regeneron Pharmaceuticals, Inc.	157,781	$121,907,911
3	INCY	Incyte Corp	693,665	$65,287,749
4	ALNY	Alnylam Pharmaceuticals, Inc.	195,277	$64,611,300
5	INSM	INSMED Inc	272,615	$44,578,004
6	JAZZ	Jazz Pharmaceuticals plc	164,542	$31,106,665
7	EXEL	Exelixis, Inc.	723,931	$31,049,400
8	ROIV	Roivant Sciences Ltd.	1,113,266	$30,837,468

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$205,655	22,476	+11.0%	Shares	Sole	2026-05-12
2025-12-31	$324,000	20,250	-19.1%	Shares	Sole	2026-02-13
2025-09-30	$1,165,385	25,019	+2.7%	Shares	Sole	2025-11-06
2025-06-30	$714,079	24,363	+35.6%	Shares	Sole	2025-08-12
2025-03-31	$461,931	17,967	-4.2%	Shares	Sole	2025-05-29
2024-12-31	$541,427	18,754	+6.2%	Shares	Sole	2025-05-29
2024-09-30	$419,105	17,654	+5.0%	Shares	Sole	2024-11-12
2024-06-30	$290,679	16,812	+265.6%	Shares	Sole	2024-08-01
2024-03-31	$102,673	4,598	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.